viral
bacteri
respiratori
tract
infect
major
caus
morbid
mortal
worldwid
despit
develop
vaccin
power
antibiot
deng
estim
million
peopl
die
infect
annual
greater
number
death
caus
hivaid
tuberculosi
combin
pandem
influenza
bacteri
pneumonia
regist
case
requir
hospit
furthermor
almost
small
autopsi
seri
highlight
import
coinfect
suggest
sever
lower
respiratori
tract
infect
caus
multipl
pathogen
act
synergi
deng
outcom
pandem
influenza
especi
sever
southern
region
brazil
sampl
posit
rate
mortal
rate
raboni
et
al
high
mortal
rate
observ
patient
led
question
presenc
factor
could
relat
sever
infect
includ
associ
bacteri
infect
therefor
studi
evalu
detect
frequenc
common
commun
bacteria
respiratori
tract
sampl
hospit
patient
acut
respiratori
infect
well
impact
coinfect
patient
influenza
pandem
specimen
collect
respiratori
tract
nasopharyng
aspir
n
bronchoalveolar
lavag
fluid
n
patient
present
acut
respiratori
infect
hospit
april
decemb
includ
studi
sampl
analyz
detect
commun
respiratori
virus
crv
investig
patient
record
review
case
report
complet
specif
notif
form
includ
medic
histori
epidemiolog
inform
laboratori
find
clinic
outcom
hospit
de
institut
ethic
review
board
approv
studi
irb
detect
character
revers
accord
center
diseas
control
prevent
cdc
protocol
detect
season
influenza
virus
viral
rna
extract
use
nuclisen
easymag
kit
marci
letoil
franc
accord
manufactur
instruct
crv
detect
use
multiplex
techniqu
brief
viral
genom
extract
use
high
pure
viral
rna
kit
roch
inc
mannheim
germani
accord
manufactur
instruct
cdna
synthes
use
random
primer
revers
transcript
system
promega
inc
madison
wi
result
cdna
subsequ
subject
pcr
use
seeplex
detect
kit
seegen
inc
seoul
south
korea
accord
manufactur
protocol
multiplex
pcr
technolog
enabl
simultan
detect
multipl
virus
includ
adenoviru
adv
coronaviru
type
cov
human
metapneumoviru
hmpv
parainfluenza
viru
type
season
influenza
flua
b
flub
respiratori
syncyti
viru
type
rsv
b
human
rhinoviru
hrv
type
b
bacteri
infect
investig
use
pneumobact
ace
detect
kit
seegen
inc
seoul
south
korea
accord
manufactur
protocol
detect
follow
pathogen
streptococcu
pneumonia
haemophilu
influenza
chlamydophila
pneumonia
mycoplasma
pneumonia
legionella
pneumophila
bordetella
pertussi
data
compil
use
jmp
version
sa
institut
inc
cari
nc
analyz
use
graphpad
prism
version
graphpad
softwar
inc
la
jolla
ca
fisher
exact
test
test
use
assess
differ
group
use
analyz
continu
variabl
appropri
continu
data
express
median
interquartil
rang
differ
median
onset
ill
calcul
nonparametr
test
univari
analysi
perform
identifi
independ
predictor
mortal
furthermor
multipl
logist
regress
analysi
includ
statist
signific
variabl
identifi
univari
analysi
p
perform
determin
variabl
risk
factor
death
level
signific
set
p
total
hospit
patient
investig
virus
bacteria
respiratori
secret
male
median
age
year
interquartil
rang
year
progress
death
patient
divid
six
group
accord
laboratori
result
sampl
posit
crv
n
sampl
posit
crv
plu
respiratori
bacteria
n
sampl
posit
n
sampl
posit
plu
respiratori
bacteria
n
sampl
posit
respiratori
bacteria
n
sampl
neg
investig
pathogen
n
demograph
data
clinic
present
radiograph
find
outcom
shown
tabl
predomin
younger
patient
observ
group
meanwhil
hospit
durat
longer
among
patient
bacteri
infect
group
frequenc
myalgia
higher
among
patient
infect
group
neg
result
group
higher
frequenc
comorbid
observ
patient
crv
bacteri
infect
group
furthermor
higher
rate
hospit
intens
care
unit
icu
greater
mortal
rate
observ
patient
infect
group
infect
predomin
radiolog
find
investig
patient
interstiti
infiltr
observ
group
regardless
bacteria
detect
includ
group
posit
bacteria
among
sampl
coinfect
bacteria
howev
among
flua
patient
also
posit
bacteria
odd
ratio
confid
interv
ci
p
respiratori
virus
detect
case
diagnos
flua
diagnos
crv
season
flua
addit
season
flua
frequent
crv
rsv
ab
hrv
ab
viral
coinfect
common
among
crv
case
flua
case
raboni
et
al
high
frequenc
bacteri
among
analyz
case
bacteria
found
posit
sampl
respect
bacteria
commonli
detect
pneumonia
h
influenza
patient
respect
bacteria
patient
rare
combin
h
influenza
pneumonia
mycoplasma
pneumonia
n
pneumonia
pneumonia
n
pneumonia
n
fig
presenc
bacteria
respiratori
tract
associ
increas
mortal
p
longer
hospit
p
interv
symptom
onset
sampl
collect
significantli
shorter
patient
posit
bacteria
neg
bacteria
p
comorbid
frequent
associ
sever
group
among
femal
patient
pregnant
howev
presenc
bacteria
infect
associ
increas
mortal
among
p
logist
regress
analysi
subsequ
perform
determin
factor
independ
predictor
mortal
univari
analysi
icu
admiss
mechan
ventil
radiolog
pattern
significantli
associ
mortal
howev
multivari
analysi
icu
admiss
ci
mechan
ventil
ci
signific
independ
predictor
mortal
overal
coinfect
detect
patient
hospit
sever
respiratori
infect
patient
exhibit
significantli
higher
mortal
rate
group
howev
presenc
bacteri
infect
associ
higher
mortal
coinfect
frequent
found
hospit
patient
crv
regard
pandem
viru
sever
infect
appear
relat
virul
pathogen
bacteria
associ
pneumonia
significantli
less
frequent
group
acut
respiratori
infect
critic
diseas
centuri
incur
high
mortal
rate
significantli
impact
frequenc
durat
hospit
well
sever
therefor
etiolog
thoroughli
investig
order
offer
patient
appropri
treatment
provid
commun
safeti
surveil
detect
emerg
pathogen
associ
influenza
bacteri
pneumonia
recogn
long
time
moren
et
al
epidemiolog
studi
centuri
demonstr
incid
pneumonia
peak
influenza
activ
et
al
tyrrel
oswald
et
al
present
find
high
rate
bacteri
coinfect
corrobor
previou
result
studi
compar
impact
coinfect
patient
outcom
report
conflict
result
coinfect
import
trigger
exacerb
asthma
chronic
obstruct
pulmonari
diseas
vitro
analys
show
respiratori
virus
promot
bacteri
infect
epitheli
disrupt
chronic
h
influenza
infect
potenti
inflammatori
respons
respiratori
virus
deng
wark
et
al
although
understand
epidemiolog
influenza
virus
chang
rapidli
bacteri
pneumonia
remain
import
contributor
sever
lethal
influenza
infect
deng
bacteri
coinfect
probabl
associ
major
pneumonia
death
influenza
pandem
report
influenza
pandem
case
manag
icu
common
pathogen
case
staphylococcu
aureu
streptococcu
pneumonia
streptococcu
pyogen
chertow
memoli
howev
even
though
bacteri
pneumonia
common
contributor
poor
outcom
variou
epidemiolog
data
suggest
incid
sever
identifi
pathogen
differ
among
epidem
geograph
locat
studi
brazil
identifi
bacteria
speci
patient
hospit
owe
commun
respiratori
infect
mauad
et
al
report
necropsi
brazilian
patient
infect
influenza
bacteri
speci
isol
three
sampl
nine
investig
patient
pneumonia
suggest
geograph
variat
bacteri
express
virul
factor
could
explain
observ
region
differ
sever
mcculler
sever
author
report
high
frequenc
pneumonia
influenza
pandem
howev
despit
patient
higher
sever
pneumonia
index
score
mortal
rate
similar
patient
without
bacteri
coinfect
dhanoa
et
al
et
al
blyth
et
al
et
al
like
coinfect
contribut
need
icu
admiss
patient
without
risk
factor
sever
influenza
diseas
blyth
et
al
american
cdc
recogn
import
earli
empir
antibiot
patient
might
concurr
bacteri
pneumonia
cdc
shieh
et
al
therefor
protocol
establish
institut
basi
evid
frequent
bacteri
coinfect
protocol
patient
admit
icu
pneumonia
even
suspect
viral
infect
receiv
antibiot
usual
combin
ceftriaxon
azithromycin
respiratori
quinolon
approach
may
associ
attenu
sever
consequ
decreas
mortal
rate
observ
studi
note
falsey
et
al
report
respiratori
virus
detect
patient
antibiot
prescrib
unnecessarili
result
increas
risk
develop
clostridium
difficil
coliti
therefor
earli
empir
antibiot
therapi
patient
unstabl
condit
appropri
without
risk
despit
interest
find
present
studi
limit
kept
mind
interpret
result
first
diagnost
valu
nasopharyng
aspir
question
pathogen
detect
asymptomat
patient
rel
common
pavia
nevertheless
preval
coinfect
differ
significantli
crv
infect
group
suggest
bacteri
posit
found
case
could
clinic
relev
moreov
obasi
et
al
report
significantli
lower
detect
rate
bacteria
respiratori
secret
healthi
adult
patient
acut
respiratori
infect
second
result
molecular
method
analyz
thu
possibl
bacteri
viral
infect
diagnos
basi
dna
rna
detect
overestim
incid
infect
often
unfeas
distinguish
colon
infect
third
presenc
viral
rna
could
mere
indic
prolong
viral
detect
follow
previou
sever
respiratori
tract
infect
therefor
factor
clinic
paramet
radiograph
pattern
biomark
use
predict
risk
bacteri
infect
falsey
et
al
fourth
although
aureu
usual
describ
associ
influenza
infect
evalu
present
studi
kit
use
detect
bacteri
cultur
perform
safeti
reason
howev
pathogen
usual
identifi
commun
respiratori
infect
region
previou
studi
brazilian
patient
die
influenza
pneumonia
also
fail
detect
speci
mauad
et
al
conclus
influenza
pandem
coinfect
frequent
hospit
patient
howev
precis
effect
coinfect
icu
admiss
remain
unclear
furthermor
higher
mortal
rate
observ
among
patient
independ
bacteria
present
final
studi
demonstr
bacteri
coinfect
commonli
associ
viral
respiratori
infect
coinfect
appear
influenc
outcom
author
contribut
develop
manuscript
approv
final
version
report
declar
compet
financi
interest
